Lung cancer is one of the most malignant cancers around the world, with high morbidity and
mortality. Metastasis is the leading cause of lung cancer deaths and treatment failure …

Lung cancer is one of the most common malignant tumors associated with cancer death;
however, the mechanisms involved in lung tumor development have not been completely …

Lung cancers are broadly divided into two categories: non-small-cell lung carcinoma
(NSCLC), which accounts for 80–85% of all cancer cases, and small-cell lung carcinoma …

A key concept in drug discovery is the identification of candidate therapeutic targets such as
long noncoding RNAs (lncRNAs) because of their extensive involvement in neoplasms, and …

MicroRNAs (miRNAs) are mighty post-transcriptional regulators in cell physiology and
pathophysiology. In this review, we focus on the role of miR-223-3p (henceforth miR-223) in …

Introduction: Hypertension is a major and modifiable risk factor for cardiovascular diseases.
Essential, primary, or idiopathic hypertension accounts for 90–95% of all cases. Identifying …

Objective: MicroRNA (miRNA), a short noncoding RNA, is claimed to be a potential blood-
based biomarker. We aimed to identify and evaluate miRNAs as diagnostic biomarkers for …

Lung cancer is the leading cause of cancer‑related mortality worldwide and cigarette
smoking is reported to contribute to the lung cancer‑related mortality. The present study …

Sarcomas are frequent in dogs and canine species are excellent animal models for studying
the human counterpart. However, osteosarcomas are a rare form of sarcoma with high death …

Lung cancer is one of the mortal cancers and the leading cause of cancer-related mortality,
with a cancer survival rate of fewer than 5% in developing nations. This low survival rate can …